Market Research Industry Reports

Chongqing Lummy Pharmaceutical Co Ltd (00006) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Chongqing Lummy Pharmaceutical Co Ltd (Lummy) is a pharmaceutical company that provides drugs and pharmaceutical ingredients. The company provides products such as tumor drugs, antibacterial drugs, antifungal drugs, antiviral agents, digestive system agents, immune system agents, blood system agents, and others. It provides cardiovascular system agents, nervous system agents, electrolyte and acid-base, liver disease auxiliaries, base large infusions, active pharmaceutical ingredients, and others. Lummys active pharmaceutical ingredients include terlipressin acetate, desmopressin acetate, atosiban acetates, thymalfasin, carbetocin and carbon nano-particles. The company operates through its distribution network in Taiwan, Hainan, Shanghai, Shandong, Anhui, Fujian, Hubei, Hunan, Jilin, among others. It operates through its branch offices located in different parts of China. Lummy is headquartered in Chongqing, China.

Chongqing Lummy Pharmaceutical Co Ltd (00006) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Argos Therapeutics Enters into Licensing Agreement with Lummy HK 10
Equity Offering 12
Chongqing Lummy Pharma to Raise USD141 Million in Private Placement of Shares 12
Debt Offering 1
Chongqing Lummy Pharma Plans to Raise up to USD77 Million in Private Placement of Bonds 1
Acquisition 14
Chongqing Lummy Pharma Plans to Acquire 5% Stake in Tibetan Teda Health and Medicine 14
Chongqing Lummy Pharma Acquires 0% Stake In Pharma Company For USD16 Million 15
Chongqing Lummy Pharma Completes Acquisition Of Remaining 40% Stake In Sichuan Hygien Pharma From Chongqing Venture Capital For US$7 Million 16
Chongqing Lummy Pharma To Acquire 60% Stake In Chengdu Jinxing Sanum-Kehlbeck For US$2 Million 17
Chongqing Lummy Pharmaceutical Co Ltd - Key Competitors 18
Chongqing Lummy Pharmaceutical Co Ltd - Key Employees 19
Chongqing Lummy Pharmaceutical Co Ltd - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List Of Tables

List of Tables
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chongqing Lummy Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Argos Therapeutics Enters into Licensing Agreement with Lummy HK 10
Chongqing Lummy Pharma to Raise USD141 Million in Private Placement of Shares 12
Chongqing Lummy Pharma Plans to Raise up to USD77 Million in Private Placement of Bonds 13
Chongqing Lummy Pharma Plans to Acquire 35% Stake in Tibetan Teda Health and Medicine 14
Chongqing Lummy Pharma Acquires 30% Stake In Pharma Company For USD16 Million 15
Chongqing Lummy Pharma Completes Acquisition Of Remaining 40% Stake In Sichuan Hygien Pharma From Chongqing Venture Capital For US$7 Million 16
Chongqing Lummy Pharma To Acquire 60% Stake In Chengdu Jinxing Sanum-Kehlbeck For US$32 Million 17
Chongqing Lummy Pharmaceutical Co Ltd, Key Competitors 18
Chongqing Lummy Pharmaceutical Co Ltd, Key Employees 19
Chongqing Lummy Pharmaceutical Co Ltd, Subsidiaries 20

List Of Figures

List of Figures
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chongqing Lummy Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Chongqing Rural Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report

Chongqing Rural Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance ReportChongqing Rural Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive

USD 175View Report

Chongqing Zhifei Biological Products Co, Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Chongqing Zhifei Biological Products Co, Ltd Company Profile is a detailed strategic and analytical report on Chongqing Zhifei Biological Products Co, Ltd. The 2018 version of the report offers detailed

USD 200View Report

Chongqing Lummy Pharmaceutical Co, Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Chongqing Lummy Pharmaceutical Co, Ltd Company Profile is a detailed strategic and analytical report on Chongqing Lummy Pharmaceutical Co, Ltd. The 2018 version of the report offers detailed insights into

USD 200View Report

Chongqing Lummy Pharmaceutical Co, Ltd Strategic Analysis Review- Chongqing Lummy Pharmaceutical Co, Ltd SWOT, Outlook, Operations and Financial Profile

Chongqing Lummy Pharmaceutical Co, Ltd Company Profile provides strategic analysis of Chongqing Lummy Pharmaceutical Co, Ltd Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Feb 2018
No. of Pages :21
Country :China
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube